Multiple-dose pharmacokinetic study of proguanil and cycloguanil following 12-hourly administration of 100 mg proguanil hydrochloride.
A pharmacokinetic study with 12-hourly doses of 100 mg proguanil hydrochloride over 15 days has been conducted in six adult male Malaysian volunteers. Steady state for proguanil was established after the fourth dose on Day 2, for the active metabolite cycloguanil as from Day 3 inclusive. The steady state mean peak concentration of proguanil was 1201.6 +/- 132.4 nmol/l, the mean trough concentration 650.0 +/- 58.1 nmol/l. The corresponding values for cycloguanil were 317.0 +/- 44.4 nmol/l (mean peak) and 230.8 +/- 35.1 nmol/l (mean trough). The profiles and peak/trough ratios of proguanil and cycloguanil with 12-hourly dosing offer better prospects for protection against malaria than those obtained with 24-hourly doses of 200 mg proguanil hydrochloride, the current routine in malaria chemoprophylaxis.
Jamaludin
A
A
National Drug Research Centre, Universiti Sains Malaysia, Penang.
Mohamad
M
M
Navaratnam
V
V
Yeoh
P Y
PY
Wernsdorfer
W H
WH
D000328:Adult; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D002727:Proguanil / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D014227:Triazines / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*
D014227:Triazines; C026009:cycloguanil; D002727:Proguanil